Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
International Seaways Inc. stock logo
INSW
International Seaways
$99.31
-0.1%
$89.00
$42.26
$102.36
$4.92B-0.13511,200 shs484,999 shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$834.04
+0.9%
$697.09
$541.00
$847.00
$85.11B0.22812,329 shs786,839 shs
RLI Corp. stock logo
RLI
RLI
$65.47
+0.6%
$60.52
$47.26
$69.19
$6.00B0.38816,222 shs566,595 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
International Seaways Inc. stock logo
INSW
International Seaways
+0.26%+2.47%+11.73%+18.76%+135.25%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
+0.90%+3.80%+28.08%+30.55%+41.12%
RLI Corp. stock logo
RLI
RLI
+0.55%+2.61%+10.50%+24.56%-3.51%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
International Seaways Inc. stock logo
INSW
International Seaways
$99.31
-0.1%
$89.00
$42.26
$102.36
$4.92B-0.13511,200 shs484,999 shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$834.04
+0.9%
$697.09
$541.00
$847.00
$85.11B0.22812,329 shs786,839 shs
RLI Corp. stock logo
RLI
RLI
$65.47
+0.6%
$60.52
$47.26
$69.19
$6.00B0.38816,222 shs566,595 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
International Seaways Inc. stock logo
INSW
International Seaways
+0.26%+2.47%+11.73%+18.76%+135.25%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
+0.90%+3.80%+28.08%+30.55%+41.12%
RLI Corp. stock logo
RLI
RLI
+0.55%+2.61%+10.50%+24.56%-3.51%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
International Seaways Inc. stock logo
INSW
International Seaways
3.00
Buy$88.00-11.39% Downside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.62
Moderate Buy$801.70-3.88% Downside
RLI Corp. stock logo
RLI
RLI
2.00
Hold$63.00-3.77% Downside

Current Analyst Ratings Breakdown

Latest INSW, REGN, and RLI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetMarket Perform$641.00 ➝ $824.00
8/13/2026
International Seaways Inc. stock logo
INSW
International Seaways
Boost Price TargetBuy$100.00 ➝ $108.00
8/7/2026
International Seaways Inc. stock logo
INSW
International Seaways
Reiterated RatingBuy (B-)
8/3/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetNeutral$700.00 ➝ $740.00
8/3/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetBuy$1,000.00 ➝ $1,030.00
7/31/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetSector Perform$696.00 ➝ $737.00
7/31/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetEqual Weight$730.00 ➝ $758.00
7/31/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetOverweight$750.00 ➝ $795.00
7/31/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetEqual Weight$700.00 ➝ $750.00
7/31/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Boost Price TargetBuy$769.00 ➝ $772.00
7/29/2026
RLI Corp. stock logo
RLI
RLI
UpgradeSell (D+)Hold (C-)
(Data available from 8/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
International Seaways Inc. stock logo
INSW
International Seaways
$843.30M5.83$8.84 per share11.24$45.74 per share2.17
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$15.53B5.53$42.36 per share19.69$308.01 per share2.71
RLI Corp. stock logo
RLI
RLI
$1.97B3.04$3.60 per share18.17$19.09 per share3.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
International Seaways Inc. stock logo
INSW
International Seaways
$309.26M$15.646.3510.94N/A61.98%31.75%23.54%11/5/2026 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.50B$40.4620.6116.511.4127.86%13.47%10.34%10/28/2026 (Estimated)
RLI Corp. stock logo
RLI
RLI
$403.34M$4.7613.7523.64N/A22.22%17.61%5.03%10/19/2026 (Estimated)

Latest INSW, REGN, and RLI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
International Seaways Inc. stock logo
INSW
International Seaways
$5.55$5.91+$0.36$5.91$406.38 million$467.29 million
7/30/2026Q2 2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$10.16$14.29+$4.13$12.23$3.82 billion$4.29 billion
7/22/2026Q2 2026
RLI Corp. stock logo
RLI
RLI
$0.7230$0.83+$0.1070$1.82$568.70 million$575.57 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
International Seaways Inc. stock logo
INSW
International Seaways
$0.480.48%+64.94%3.07%N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.760.45%N/A9.29%N/A
RLI Corp. stock logo
RLI
RLI
$0.721.10%+21.83%15.13%51 Years

Latest INSW, REGN, and RLI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2026
International Seaways Inc. stock logo
INSW
International Seaways
quarterly$5.0522.47%9/10/20269/10/20269/24/2026
8/13/2026
RLI Corp. stock logo
RLI
RLI
quarterly$0.181.12%8/31/20268/31/20269/15/2026
7/30/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.940.46%8/18/20268/18/20268/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
International Seaways Inc. stock logo
INSW
International Seaways
0.27
5.94
5.76
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.06
3.34
2.78
RLI Corp. stock logo
RLI
RLI
N/A
0.33
0.33

Institutional Ownership

CompanyInstitutional Ownership
International Seaways Inc. stock logo
INSW
International Seaways
67.29%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
RLI Corp. stock logo
RLI
RLI
77.89%

Insider Ownership

CompanyInsider Ownership
International Seaways Inc. stock logo
INSW
International Seaways
1.70%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
6.97%
RLI Corp. stock logo
RLI
RLI
2.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
International Seaways Inc. stock logo
INSW
International Seaways
2,76349.53 million48.69 millionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
15,410102.96 million95.78 millionOptionable
RLI Corp. stock logo
RLI
RLI
1,19391.77 million89.58 millionOptionable

Recent News About These Companies

RLI Corp. (NYSE:RLI) Receives Consensus Rating of "Hold" from Analysts
NewEdge Wealth LLC Takes Position in RLI Corp. $RLI
Zacks Research Issues Positive Outlook for RLI Earnings
Zacks Research Issues Negative Estimate for RLI Earnings
MERLIN ($MRLN) Releases Q2 2026 Earnings
Wasatch Advisors LP Grows Position in RLI Corp. $RLI

New MarketBeat Followers Over Time

Media Sentiment Over Time

International Seaways stock logo

International Seaways NYSE:INSW

$99.31 -0.05 (-0.05%)
As of 08/21/2026 03:58 PM Eastern

International Seaways, Inc. owns and operates a fleet of oceangoing vessels for the transportation of crude oil and petroleum products in the international flag trade. It operates in two segments: Crude Tankers and Product Carriers. As of December 31, 2023, the company owned a fleet of 73 vessels. It serves independent and state-owned oil companies, oil traders, refinery operators, and international government entities. The company was formerly known as OSG International, Inc. and changed its name to International Seaways, Inc. in October 2016. International Seaways, Inc. was incorporated in 1999 and is headquartered in New York, New York.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$834.04 +7.40 (+0.90%)
As of 08/21/2026 04:00 PM Eastern

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

RLI stock logo

RLI NYSE:RLI

$65.47 +0.37 (+0.57%)
As of 08/21/2026 03:58 PM Eastern

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile. It also offers coverages for security guards and environmental liability for underground storage tanks, contractors and asbestos, and environmental remediation specialists; and professional liability coverages for errors and omission coverage for small to medium-sized design, technical, computer, and miscellaneous professionals. This segment provides commercial automobile liability and physical damage insurance to local, intermediate and long haul truckers, public transportation entities, and other types of specialty commercial automobile risks; incidental and related insurance coverages; inland marine coverages; management liability coverages, such as directors and officers liability insurance, fiduciary liability and coverages, employment practice liability, and for various classes of risks, including public and private businesses; and home business insurance products. The company's Property segment offers commercial property, cargo, hull, protection and indemnity, marine liability, inland marine, homeowners' and dwelling fire, and other property insurance products. Its Surety segment offers commercial surety bonds for medium to large-sized businesses; small bonds for businesses and individuals; and bonds for small to medium-sized contractors. The company also engages in various reinsurance coverages. It markets its products through branch offices, wholesale and retail brokers, carrier partners, and underwriting and independent agents. RLI Corp. was incorporated in 1965 and is headquartered in Peoria, Illinois.